alexa Anti-inflammatory Drug Peer Review Journals|OMICS International|Translational Medicine

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Anti-inflammatory Drug Peer Review Journals

OMICS Group International is one of the leading Open Access Publishing houses, which has around 700+ peer-reviewed journals, 50,000+ editorial board members, and highly qualified, expert reviewers to meet the objectives of the Peer-Review Process. OMICS Group International peer-review policies are highly appreciated, accepted and adaptable to the criteria that have been prescribed by the international agencies such as NIH, PubMed etc. OMICS Group International also organizes 3000+ International Scientific Conferences per year globally. There is a great deal of information out there on scientific topics. However, whether it can be trusted or not is a key issue at present. The main question that often emerges in this aspect is about the review process adopted to screen the articles for publication. One of the most acceptable and proven process adopted in majority reputed international journals is peer reviewing. Inflammatory diseases are one of the major health problems worldwide. Acute and chronic inflammations are induced by several chemical mediators such as prostaglandins, leukotrienes and platelet-activating factor. Anti-inflammatory agents show their activities through several activity mechanisms. Non-steroid antiinflammatory drugs (NSAIDs) are the most prescribed drugs for treatment of inflammatory diseases. The NSAIDs provide the patients with symptomatic relief, however, they do not modify the pathogenesis of inflammation. Furthermore, prolonged use should be avoided due to severe side effects particularly on gastric mucosa. Therefore, searching for new drug candidates in the treatment of chronic inflammation has great importance. The scientific researches on the biological effects of the medicinal plants led to the discovery and development of novel bioactive drug molecules. Indeed, natural products have proved to be a rich source of therapeutic agents. Due to the side effects caused mostly by synthetic drugs, research into natural products has advanced tremendously in academia and pharmaceutical companies. In vivo and in vitro anti-inflammatory, antinociceptive and antipyretic evaluations of medicinal plants provide scientific evidence for the ethnomedicinal features.(EsraKüpeliAkkol, New Strategies for Anti-Inflammatory Drug Development)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014

Top